Page last updated: 2024-11-10

muricatacin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

muricatacin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3035657
CHEMBL ID487910
CHEBI ID185820
MeSH IDM0219775

Synonyms (9)

Synonym
muricatacin
(-)-muricatacin
CHEMBL487910
(5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-one
134698-86-5
CHEBI:185820
(+)-5-epi-muricatacin
2(3h)-furanone, dihydro-5-(1-hydroxytridecyl)-, (r-(r*,r*))-
DTXSID10158864
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
long-chain fatty alcoholA fatty alcohol with a chain length ranging from C13 to C22.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID349331Antiproliferative activity against human Jurkat cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Design, synthesis and antiproliferative activity of two new heteroannelated (-)-muricatacin mimics.
AID349333Antiproliferative activity against human MRC5 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Design, synthesis and antiproliferative activity of two new heteroannelated (-)-muricatacin mimics.
AID349332Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Design, synthesis and antiproliferative activity of two new heteroannelated (-)-muricatacin mimics.
AID349329Antiproliferative activity against human K562 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Design, synthesis and antiproliferative activity of two new heteroannelated (-)-muricatacin mimics.
AID349330Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Design, synthesis and antiproliferative activity of two new heteroannelated (-)-muricatacin mimics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (14.29)18.2507
2000's8 (57.14)29.6817
2010's2 (14.29)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.15 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]